Search results for "cyclooxygenase"

showing 10 items of 235 documents

Biowaiver monograph for immediate-release solid oral dosage forms: acetylsalicylic acid.

2012

A biowaiver monograph for acetylsalicylic acid (ASA) is presented. Literature and experimental data indicate that ASA is a highly soluble and highly permeable drug, leading to assignment of this active pharmaceutical ingredient (API) to Class I of the Biopharmaceutics Classification System (BCS). Limited bioequivalence (BE) studies reported in the literature indicate that products that have been tested are bioequivalent. Most of the excipients used in products with a marketing authorization in Europe are not considered to have an impact on gastrointestinal motility or permeability. Furthermore, ASA has a wide therapeutic index. Thus, the risks to the patient that might occur if a nonbioequi…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological AvailabilityPharmacologyBioequivalenceMarketing authorizationDosage formDrug StabilityFibrinolytic AgentsAnimalsHumansCyclooxygenase Inhibitorsmedia_commonActive ingredientAspirinChemistryAnti-Inflammatory Agents Non-SteroidalBiopharmaceutics Classification SystemSolubilityTherapeutic EquivalencyPlatelet aggregation inhibitorCaco-2 CellsFibrinolytic agentPlatelet Aggregation InhibitorsTabletsJournal of pharmaceutical sciences
researchProduct

Therapeutic administration of 3,4,5-trimethoxy-4'-fluorochalcone, a selective inhibitor of iNOS expression, attenuates the development of adjuvant-in…

2003

We have previously investigated the effects of a series of dimethoxy- and trimethoxychalcone derivatives, with various patterns of fluorination, on nitric oxide production in LPS-stimulated murine RAW 264.7. The present study was designed to determine if 3,4,5-trimethoxy-4'-fluorochalcone (CH 17) could modulate the production of NO and/or prostaglandins in vivo. On the mouse macrophage cell line RAW 264.7 CH 17 inhibited dose-dependently NO production, with an IC(50) value in the nanomolar range, and reduced PGE(2) levels by a 58% at 10 microM. This compound had no direct inhibitory effect on iNOS and COX-2 activities. NO reduction was the consequence of inhibition of the expression of iNOS…

ElectrophoresisMaleBlotting WesternNitric Oxide Synthase Type IIArthritisPharmacologyNitric OxideMonocytesNitric oxideMicechemistry.chemical_compoundChalconeChalconesIn vivoOral administrationmedicineAnimalsHumansEnzyme InhibitorsProstaglandin E2IC50Cells CulturedPharmacologyDose-Response Relationship DrugNF-kappa BMembrane ProteinsGeneral Medicinemedicine.diseaseArthritis ExperimentalIn vitroRatsIsoenzymesDose–response relationshipBiochemistrychemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesRats Inbred LewCyclooxygenase 1Nitric Oxide Synthasemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Incorporation and metabolism of trans 20∶5 in endothelial cells. Effect on prostacyclin synthesis

2000

To study the ability of long-chain trans fatty acids (FA) to be incorporated and metabolized into endothelial cells, bovine aortic endothelial cells were incubated with medium enriched eicosapentaenoic acid (EPA) bound to albumin (M2) or one of its geometrical isomers: 20:5 5c,8c,11t,14c,17c (M3), 20:5 5c,8c,11c,14c,17t (M4), or 20:5 5c,8c,11t,14c,17t (M5). After 48 h of incubation, supernatant and cells were harvested and their lipids were analyzed, including prostacyclin synthesis. EPA and 22:5n-3 of endothelial cells incubated with M2 were, respectively, three and two times higher than in control cells (incubated in M1, without any fatty acid added), whereas 22:6n-3 increased only in the…

Endothelium030309 nutrition & dieteticsPhospholipidSerum albuminBiochemistryGas Chromatography-Mass SpectrometryMass SpectrometryCyclooxygenase pathway03 medical and health scienceschemistry.chemical_compoundmedicineAnimals[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry Molecular Biology/Biochemistry [q-bio.BM][SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry Molecular Biology/Biochemistry [q-bio.BM]AortaChromatography High Pressure LiquidSerum AlbuminComputingMilieux_MISCELLANEOUS030304 developmental biologychemistry.chemical_classification0303 health sciencesFourier AnalysisbiologyFatty AcidsOrganic ChemistryFatty acidCell BiologyMetabolismEpoprostenolLipidsEicosapentaenoic acidCulture Mediamedicine.anatomical_structureEicosapentaenoic AcidchemistryBiochemistryProstaglandin-Endoperoxide SynthasesProstaglandinsbiology.proteinCattleArachidonic acidEndothelium VascularLipids
researchProduct

Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow

2005

The main mechanism of action of non-steroidal anti-inflammatory drugs (NSAIDs) is the inhibition of cycloxygenases COX-1 and COX-2. During recent years, combined 5-LOX/COX-inhibition, interfering with the biosynthesis of both prostaglandins and leukotrienes (LTs), has emerged as a possibility to avoid side effects related to COX-inhibition. The aim of the present study was to investigate if there is a contribution of mechanisms other than the reduction of inflammatory prostaglandins and leukotrienes to the anti-inflammatory effect of the LOX/COX inhibitor licofelone. In a flow chamber assay, licofelone (10-30 microM) dose-dependently decreased both the rolling and adhesion of leukocytes on …

EndotheliumAcetatesPharmacologyBiochemistrychemistry.chemical_compoundCell MovementIn vivoCell AdhesionLeukocytesmedicineHumansCyclooxygenase InhibitorsPyrrolesLipoxygenase InhibitorsRNA MessengerCells CulturedPharmacologybiologyChemistryEndothelial Cellsmedicine.anatomical_structureMechanism of actionImmunologyArachidonate 5-lipoxygenaseCelecoxibbiology.proteinCyclooxygenasemedicine.symptomLicofeloneCell Adhesion MoleculesSelectinmedicine.drugBiochemical Pharmacology
researchProduct

Molecular characterisation of Galba truncatula, Lymnaea neotropica and L. schirazensis from Cajamarca, Peru and their potential role in transmission …

2012

Abstract Background Human and animal fascioliasis is emerging in many world regions, among which Andean countries constitute the largest regional hot spot and Peru the country presenting more human endemic areas. A survey was undertaken on the lymnaeid snails inhabiting the hyperendemic area of Cajamarca, where human prevalences are the highest known among the areas presenting a "valley transmission pattern", to establish which species are present, genetically characterise their populations by comparison with other human endemic areas, and discuss which ones have transmission capacity and their potential implications with human and animal infection. Methods Therefore, ribosomal DNA ITS-2 an…

EntomologyDisease reservoirMitochondrial DNAFascioliasisSnailsZoologyDNA MitochondrialPolymerase Chain ReactionHost-Parasite Interactionslcsh:Infectious and parasitic diseasesRNA Ribosomal 16SPeruFasciola hepaticaAnimalsHumanslcsh:RC109-216Galba truncatulaDisease ReservoirsPopulation DensityFasciolabiologyBase SequenceEcologyResearchbiology.organism_classificationFasciolaInfectious DiseasesGalbaParasitologyLarvaCyclooxygenase 1ParasitologyParasites & Vectors
researchProduct

Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production

2004

Increased Abeta42 production has been linked to the development of Alzheimer disease. We now identify a number of compounds that raise Abeta42. Among the more potent Abeta42-raising agents identified are fenofibrate, an antilipidemic agent, and celecoxib, a COX-2-selective NSAID. Many COX-2-selective NSAIDs tested raised Abeta42, including multiple COX-2-selective derivatives of two Abeta42-lowering NSAIDs. Compounds devoid of COX activity and the endogenous isoprenoids FPP and GGPP also raised Abeta42. These compounds seem to target the gamma-secretase complex, increasing gamma-secretase-catalyzed production of Abeta42 in vitro. Short-term in vivo studies show that two Abeta42-raising comp…

Enzyme-Linked Immunosorbent AssayEndogenyProtein Serine-Threonine KinasesPharmacologyTransfectionMass SpectrometryGeneral Biochemistry Genetics and Molecular BiologyPresenilinCell LineFenofibrateAlzheimer DiseaseIn vivoEndopeptidasesmedicineAspartic Acid EndopeptidasesHumansImmunoprecipitationCyclooxygenase InhibitorsProtein precursorHypolipidemic AgentsSulfonamidesrho-Associated KinasesAmyloid beta-PeptidesFenofibratebusiness.industryAnti-Inflammatory Agents Non-SteroidalIntracellular Signaling Peptides and ProteinsBrainGeneral Medicinemedicine.diseaseIn vitroEnzyme ActivationBiochemistryCelecoxibPyrazolesFemaleAmyloid Precursor Protein SecretasesAlzheimer's diseaserhoA GTP-Binding ProteinbusinessAntilipidemic Agentmedicine.drugNature Medicine
researchProduct

DNA sequence characterisation and phylogeography of Lymnaea cousini and related species, vectors of fascioliasis in northern Andean countries, with d…

2011

Abstract Background Livestock fascioliasis is a problem throughout Ecuador, Colombia and Venezuela, mainly in Andean areas where the disease also appears to affect humans. Transmission patterns and epidemiological scenarios of liver fluke infection have shown to differ according to the lymnaeid vector snail species involved. These Andean countries present the vectors Lymnaea cousini, L. bogotensis and L. ubaquensis, unknown in the rest of Latin America. An exhaustive combined haplotype study of these species is performed by means of DNA sequencing of the nuclear ribosomal 18S RNA gene, ITS-2 and ITS-1, and mitochondrial DNA cox 1 gene. Results The conserved 5.8S rDNA sequence corroborated t…

FascioliasisMitochondrial DNAPseudosuccinea columellaMolecular Sequence DataZoologyColombiaDisease VectorsDNA Ribosomal18S ribosomal RNALymnaeidaelcsh:Infectious and parasitic diseasesHepaticaDNA Ribosomal SpacerRNA Ribosomal 18SAnimalsCluster Analysislcsh:RC109-216LymnaeabiologyPhylogenetic treeResearchSequence Analysis DNAVenezuelabiology.organism_classificationRNA Ribosomal 5.8SPhylogeographyPhylogeographyInfectious DiseasesCyclooxygenase 1MicrosatelliteParasitologyEcuadorParasites & Vectors
researchProduct

Flavonoids from Acacia pennata and their Cyclooxygenase (COX-1 and COX-2) Inhibitory Activities

2007

Two new flavonoids quercetin 4'-O-alpha-L-rhamnopyranosyl-3-O-beta-D-allopyranoside (1) and apigenin 6-C-[2''-O-(E)-feruloyl- beta-D-glucopyranosyl]-8-C-beta-glucopyranoside (2), along with the known isorhamnetin 3-O-alpha-L-rhamnopyranoside (3), kaempferol 3-O-alpha-L-rhamnopyranosyl-(1-->4)-beta-D-glucopyranoside (4), and isovitexin (5) were isolated from the leaves of Acacia pennata Willd. (Mimosaceae) and tested for their anti-inflammatory activity. Their structures were determined by 1D and 2D NMR and mass spectrometry. They were tested for an inhibitory effect on COX-1 and COX-2, showing 60-90% inhibition at 10(-4) g/mL and 5-14% inhibition at 10(-4) g/mL, respectively.

FlavonoidIsovitexinPharmaceutical ScienceBiologyPharmacognosyAnalytical ChemistryInhibitory Concentration 50chemistry.chemical_compoundDrug DiscoveryHumansCyclooxygenase InhibitorsPhenolsIsorhamnetinPharmacologychemistry.chemical_classificationTraditional medicinePlant ExtractsOrganic ChemistryAcaciaFlavonesPlant LeavesComplementary and alternative medicinechemistryBiochemistryCyclooxygenase 2ApigeninCyclooxygenase 1Molecular MedicineKaempferolQuercetinPhytotherapyPlanta Medica
researchProduct

Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach.

2022

© Crown 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the per…

GENERAL-POPULATIONAgingEvidence-Based MedicinePLACEBOPatient-centeredNONSTEROIDAL ANTIINFLAMMATORY DRUGSOsteoarthritis KneeAMERICAN-COLLEGEKNEE OSTEOARTHRITISHandCYCLOOXYGENASE-2 INHIBITORSManagementEuropeDOUBLE-BLINDPatient-Centered CareHEALTH-CAREOsteoarthritisJOINT OSTEOARTHRITISHumansADVERSE EVENTSGeriatrics and GerontologyHand Management Osteoarthritis Patient-centered Treatment guidelineReferral and ConsultationTreatment guideline
researchProduct

Immunohistochemical localization of cyclooxygenase isoforms in the organ of Corti and the spiral ganglion cells of guinea pig cochlea.

2003

Prostaglandins have been used in experimental models and clinical studies for the therapy of sudden hearing loss and tinnitus with conflicting results. However, little is known about the rate-limiting enzymes of prostaglandin synthesis in the inner ear, the generally constitutively expressed cyclooxygenase 1 (COX-1) and the distress-inducible cycloxygenase 2 (COX-2). To extend our knowledge concerning the physiological expression and localization of these two enzymes, immunohistochemical stainings of the guinea pig cochlea were performed. Light microscopical analysis revealed a homogenous distribution of COX-1 within nearly all cell types of the organ of Corti, but no COX-1 expression in th…

Gene isoformCell typePathologymedicine.medical_specialtyGuinea PigsBiologyGuinea pigTinnitusProstaglandins Syntheticotorhinolaryngologic diseasesmedicineAnimalsInner earOrgan of CortiSpiral ganglionCochleaHearing Loss SuddenImmunohistochemistryCell biologyDisease Models Animalmedicine.anatomical_structureOtorhinolaryngologyOrgan of CortiCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesCyclooxygenase 1Deiters cellssense organsSpiral GanglionORL; journal for oto-rhino-laryngology and its related specialties
researchProduct